4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-24-007457
CHIEF OPERATING OFFICER sold 4,875 shares at $15.64 ($76,239)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Patel Anish · CHIEF OPERATING OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-06 | Sale : show line 1 in the form 10b5-1 | −4,875 | $15.64 | $76,239 | 7,472 | D |
| Open-market sales · 4,875 sh · avg $15.64 · $76,239 | ||||||
Loading xslF345X05/form4-03092024_120325.xml…